<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Three-Dimensional Quantitative Assessment of Lesion Response to MR-guided High-Intensity Focused Ultrasound Treatment of Uterine Fibroids" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/three-dimensional-quantitative-assessment-of-lesion-response-to-mr-guided-high-intensity-focused-ult/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/three-dimensional-quantitative-assessment-of-lesion-response-to-mr-guided-high-intensity-focused-ult/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2015-08-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Three-Dimensional Quantitative Assessment of Lesion Response to MR-guided High-Intensity Focused Ultrasound Treatment of Uterine Fibroids" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T03:59:08+00:00","datePublished":"2015-08-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Three-Dimensional Quantitative Assessment of Lesion Response to MR-guided High-Intensity Focused Ultrasound Treatment of Uterine Fibroids","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/three-dimensional-quantitative-assessment-of-lesion-response-to-mr-guided-high-intensity-focused-ult/"},"url":"https://clinicaltree.github.io/posts/three-dimensional-quantitative-assessment-of-lesion-response-to-mr-guided-high-intensity-focused-ult/"}</script><title>Three-Dimensional Quantitative Assessment of Lesion Response to MR-guided High-Intensity Focused Ultrasound Treatment of Uterine Fibroids | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Three-Dimensional Quantitative Assessment of Lesion Response to MR-guided High-Intensity Focused Ultrasound Treatment of Uterine Fibroids</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Three-Dimensional Quantitative Assessment of Lesion Response to MR-guided High-Intensity Focused Ultrasound Treatment of Uterine Fibroids</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1441040400" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Aug 31, 2015 </em> </span> <span> Updated <em class="" data-ts="1681099148" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Lynn J. Savic BS</a> </em>, <em> <a href="">MingDe Lin PhD</a> </em>, <em> <a href="">Rafael Duran MD</a> </em>, <em> <a href="">Rüdiger E. Schernthaner MD</a> </em>, <em> <a href="">Bernd Hamm MD</a> </em>, <em> <a href="">Jean-François Geschwind MD</a> </em>, <em> <a href="">Kelvin Hong MD</a> </em>, <em> <a href="">Julius Chapiro MD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1572 words"> <em>8 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>To investigate the response after magnetic resonance–guided high-intensity focused ultrasound (MRgHIFU) treatment of uterine fibroids (UF) using a three-dimensional (3D) quantification of total and enhancing lesion volume (TLV and ELV, respectively) on contrast-enhanced MRI (ceMRI) scans.</p><h2 id="methods-and-materials"><span class="mr-2">Methods and Materials</span><a href="#methods-and-materials" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>In a total of 24 patients, ceMRI scans were obtained at baseline and 24 hours, and 6, 12, and 24 months after MRgHIFU treatment. The dominant lesion was assessed using a semiautomatic quantitative 3D segmentation technique. Agreement between software-assisted and manual measurements was then analyzed using a linear regression model. Patients were classified as responders (R) or nonresponders (NR) on the basis of their symptom report after 6 months. Statistical analysis included the paired <em>t</em> –test and Mann–Whitney test.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Preprocedurally, the median TLV and ELV were 263.74 cm 3 (30.45–689.56 cm 3 ) and 210.13 cm 3 (14.43–689.53 cm 3 ), respectively. The 6-month follow-up demonstrated a reduction of TLV in 21 patients (87.5%) with a median TLV of 171.7 cm 3 (8.5–791.2 cm 3 ; <em>P</em> &lt; .0001). TLV remained stable with significant differences compared to baseline ( <em>P</em> &lt; .001 and <em>P</em> = .047 after 12 and 24 months). A reduction of ELV was apparent in 16 patients (66.6%) with a median ELV of 158.91 cm 3 (8.55–779.61 cm 3 ) after 6 months ( <em>P</em> = .065). Three-dimensional quantification and manual measurements showed strong intermethod agreement for fibroid volumes ( <em>R</em> 2 = .889 and .917) but greater discrepancy for enhancement calculations ( <em>R</em> 2 = .659 and .419) at baseline and 6 months. No significant differences in TLV or ELV were observed between clinical R ( <em>n</em> = 15) and NR ( <em>n</em> = 3).</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The 3D assessment has proven feasible and accurate in the quantification of fibroid response to MRgHIFU. Contrary to ELV, changes in TLV may be representative of the clinical outcome.</p><p>Uterine fibroids (UF) represent one of the most common benign tumors that predominantly occur in the perimenopausal years . Location, size, and multiplicity of UF are varying, resulting in a diversity of clinical presentations that range from asymptomatic to symptoms which highly interfere with the patient’s quality of life . As for the treatment of UF, surgical removal (myomectomy or hysterectomy) remains the gold standard, and UF represents the major indication for hysterectomy . However, there are minimal invasive treatment options including radiofrequency ablation and catheter-based approaches, such as uterine artery (UAE), which have become well-accepted alternatives to surgery over the last decades .</p><p>Magnetic resonance–guided high-intensity focused ultrasound (MRgHIFU) represents another approach and is the only fully noninvasive alternative in the treatment of UF. MRgHIFU uses targeted energy deposition from focused ultrasound under MR guidance to ablate the tissue by thermal coagulation and acoustic cavitation . MRgHIFU has proved as safe, feasible, and effective in reducing clinical symptoms .</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="study-cohort"><span class="mr-2">Study Cohort</span><a href="#study-cohort" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="clinical-evaluation"><span class="mr-2">Clinical Evaluation</span><a href="#clinical-evaluation" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mrghifu-procedure-and-follow-up-imaging"><span class="mr-2">MRgHIFU Procedure and Follow-up Imaging</span><a href="#mrghifu-procedure-and-follow-up-imaging" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="imaging-data-evaluation3d-quantification-of-lesion-response"><span class="mr-2">Imaging Data Evaluation—3D Quantification of Lesion Response</span><a href="#imaging-data-evaluation3d-quantification-of-lesion-response" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="lesion-segmentation"><span class="mr-2">Lesion Segmentation</span><a href="#lesion-segmentation" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="3d-resqu-technique"><span class="mr-2">3D-RESQU Technique</span><a href="#3d-resqu-technique" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ThreeDimensionalQuantitativeAssessmentofLesionResponsetoMRguidedHighIntensityFocusedUltrasoundTreatmentofUterineFibroids/0_1s20S1076633215002469.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ThreeDimensionalQuantitativeAssessmentofLesionResponsetoMRguidedHighIntensityFocusedUltrasoundTreatmentofUterineFibroids/0_1s20S1076633215002469.jpg" alt="Figure 1, Quantification of the total lesion volume and enhancing lesion volume. The graph (median and standard error) demonstrates the (a) total lesion volume (TLV) and the (b) enhancing lesion volume (ELV) assessed by three-dimensional response quantification in uterine fibroids on contrast-enhanced MRI (ceMRI) scans at baseline, 24 hours, 6, 12, and 24 months after magnetic resonance–guided high-intensity focused ultrasound (MRgHIFU). A TLV decrease of statistical significance compared to baseline was observed after 6, 12, and 24 months. A significant decrease of ELV was apparent after 12 months.* P &lt; .05, ** P &lt; .01, *** P &lt; .001." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ThreeDimensionalQuantitativeAssessmentofLesionResponsetoMRguidedHighIntensityFocusedUltrasoundTreatmentofUterineFibroids/1_1s20S1076633215002469.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ThreeDimensionalQuantitativeAssessmentofLesionResponsetoMRguidedHighIntensityFocusedUltrasoundTreatmentofUterineFibroids/1_1s20S1076633215002469.jpg" alt="Figure 2, Three-dimensional quantitative assessment of uterine fibroids. The graph illustrates representative changes in the total lesion volume (TLV) and the enhancing lesion volume (ELV) of a uterine fibroid after magnetic resonance–guided high-intensity focused ultrasound (MRgHIFU) in a 44-year-old patient. In the vertical, the contrast-enhanced MRI (ceMRI) scans are arranged according to the time of acquisition. (a,b) The ceMRI scans at 0 and 20 seconds, respectively. (c) The volume rendering for the segmented lesion on a ceMRI scan. (d) The color map of the lesion using three-dimensional response quantification in uterine fibroids; the color coding varies from red representing maximum enhancement to blue representing no enhancement." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="manual-image-analysis"><span class="mr-2">Manual Image Analysis</span><a href="#manual-image-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="study-population"><span class="mr-2">Study Population</span><a href="#study-population" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Patient Characteristics</p><p>Parameter Study Population, <em>n</em> Age ( <em>n</em> = 24) 46.13 ∗ years (range, 37–53) Race African American 9 White 13 Other 2 Clinical symptoms at presentation (n = 19) Menorrhagia 13 (68%) Bulk-related symptoms 16 (84%) Number of uterine fibroids 1 9 2 9 &gt;2 6 Baseline TLV ( <em>n</em> = 24) 263.74 ∗ cm 3 (range, 30.45–689.56)</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="imaging-results"><span class="mr-2">Imaging Results</span><a href="#imaging-results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="volumetric-assessment-itlv"><span class="mr-2">Volumetric Assessment I—TLV</span><a href="#volumetric-assessment-itlv" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="volumetric-assessment-iielv"><span class="mr-2">Volumetric Assessment II—ELV</span><a href="#volumetric-assessment-iielv" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="manual-and-visual-image-analysis"><span class="mr-2">Manual and Visual Image Analysis</span><a href="#manual-and-visual-image-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ThreeDimensionalQuantitativeAssessmentofLesionResponsetoMRguidedHighIntensityFocusedUltrasoundTreatmentofUterineFibroids/2_1s20S1076633215002469.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ThreeDimensionalQuantitativeAssessmentofLesionResponsetoMRguidedHighIntensityFocusedUltrasoundTreatmentofUterineFibroids/2_1s20S1076633215002469.jpg" alt="Figure 3, Correlation analysis: uterine fibroid volume. The graphs illustrate the interreader agreement for manual volume measurements (a,b) and the intermethod correlation between manual assessment and three-dimensional response quantification of the total lesion volume (TLV) in uterine fibroids (3D-RESQU) on contrast-enhanced MRI scans (c,d). Uterine fibroid volumes were assessed at baseline and 6 months after magnetic resonance–guided high-intensity focused ultrasound (MRgHIFU). According to the linear regression model and the calculation of the Pearson correlation coefficient ( R 2 ), volumes measured manually by both readers demonstrate good agreement and the strong correlation of both attempts validates volumetric calculations by the semiautomatic 3D-RESQU technique in this setting." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ThreeDimensionalQuantitativeAssessmentofLesionResponsetoMRguidedHighIntensityFocusedUltrasoundTreatmentofUterineFibroids/3_1s20S1076633215002469.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ThreeDimensionalQuantitativeAssessmentofLesionResponsetoMRguidedHighIntensityFocusedUltrasoundTreatmentofUterineFibroids/3_1s20S1076633215002469.jpg" alt="Figure 4, Correlation analysis: uterine fibroid enhancement. The graphs illustrate the interreader agreement for visual enhancement assessments (a,b) and the intermethod correlation between visual measurement and three-dimensional response quantification of the enhancing lesion volume (ELV) in uterine fibroids (3D-RESQU) on contrast-enhanced MRI scans (c,d). Uterine Fibroid enhancement was analyzed at baseline and 6 months after magnetic resonance–guided high-intensity focused ultrasound (MRgHIFU). According to the linear regression model and the calculation of the Pearson correlation coefficient ( R 2 ), visually estimated enhancements only show slight agreement and thereby demonstrate limited reproducibility. The correlation analysis of both attempts reveals strong discrepancy, particularly at the 6-month follow-up, suggesting a benefit of the semiautomatic 3D-RESQU technique over a planar visual approach." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="clinical-results"><span class="mr-2">Clinical Results</span><a href="#clinical-results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Cramer S.F., Patel A.: The frequency of uterine leiomyomas. Am J Clin Pathol 1990; 94: pp. 435-438. PubMed PMID: 2220671</p><li><p>2. Flake G.P., Andersen J., Dixon D.: Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 2003; 111: pp. 1037-1054. PubMed PMID: 12826476; PubMed Central PMCID: PMCPMC1241553</p><li><p>3. Kröncke T., David M.: [Uterine artery embolization (UAE) for fibroid treatment: results of the 4th Radiological Gynecological Expert Meeting]. Rofo 2013; 185: pp. 461-463. PubMed PMID: 23572203</p><li><p>4. Kröncke T.J., Hamm B.: [Role of magnetic resonance imaging (MRI) in establishing the indication for, planning, and following up uterine artery embolization (UAE) for treating symptomatic leiomyomas of the uterus]. Radiologe 2003; 43: pp. 624-633. PubMed PMID: 14504762</p><li><p>5. ter Haar G.: High intensity ultrasound. Semin Laparosc Surg 2001; 8: pp. 77-89. PubMed PMID: 11337740</p><li><p>6. ter Haar G.: Ultrasound bioeffects and safety. Proc Inst Mech Eng H 2010; 224: pp. 363-373. PubMed PMID: 20349824</p><li><p>7. Fan R., Zhu L., Gong X.M., et. al.: [Prospective study on magnetic resonance-guided focused ultrasound surgery for symptomatic uterine fibroid: short-term follow up]. Zhonghua Fu Chan Ke Za Zhi 2013; 48: pp. 183-187. PubMed PMID: 23849940</p><li><p>8. Stewart E.A., Rabinovici J., Tempany C.M., et. al.: Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 2006; 85: pp. 22-29. PubMed PMID: 16412721</p><li><p>9. Kim H.S., Baik J.H., Pham L.D., et. al.: MR-guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata: long-term outcomes. Acad Radiol 2011; 18: pp. 970-976. PubMed PMID: 21718955; PubMed Central PMCID: PMCPMC3401073</p><li><p>10. Kroencke T.J., Scheurig C., Poellinger A., et. al.: Uterine artery embolization for leiomyomas: percentage of infarction predicts clinical outcome. Radiology 2010; 255: pp. 834-841. PubMed PMID: 20392986</p><li><p>11. Fennessy F.M., Tempany C.M., McDannold N.J., et. al.: Uterine leiomyomas: MR imaging-guided focused ultrasound surgery—results of different treatment protocols. Radiology 2007; 243: pp. 885-893. PubMed PMID: 17446521</p><li><p>12. Spies J.B., Coyne K., Guaou Guaou N., et. al.: The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol 2002; 99: pp. 290-300. PubMed PMID: 11814511</p><li><p>13. Tacher V., Lin M., Chao M., et. al.: Semiautomatic volumetric tumor segmentation for hepatocellular carcinoma: comparison between C-arm cone beam computed tomography and MRI. Acad Radiol 2013; 20: pp. 446-452. PubMed PMID: 23498985; PubMed Central PMCID: PMCPMC3602801</p><li><p>14. Duran R., Chapiro J., Frangakis C., et. al.: Uveal melanoma metastatic to the liver: the role of quantitative volumetric contrast-enhanced MR imaging in the assessment of early tumor response after transarterial chemoembolization. Transl Oncol 2014; PubMed PMID: 24953419</p><li><p>15. Chapiro J., Wood L.D., Lin M., et. al.: Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis. Radiology 2014; pp. 140033. PubMed PMID: 25028783</p><li><p>16. Froeling V., Meckelburg K., Schreiter N.F., et. al.: Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results. Eur J Radiol 2013; 82: pp. 2265-2269. PubMed PMID: 24075785</p><li><p>17. Yoon S.W., Cha S.H., Ji Y.G., et. al.: Magnetic resonance imaging-guided focused ultrasound surgery for symptomatic uterine fibroids: estimation of treatment efficacy using thermal dose calculations. Eur J Obstet Gynecol Reprod Biol 2013; 169: pp. 304-308. PubMed PMID: 23523412</p><li><p>18. Hesley G.K., Gorny K.R., Woodrum D.A.: MR-guided focused ultrasound for the treatment of uterine fibroids. Cardiovasc Intervent Radiol 2013; 36: pp. 5-13. PubMed PMID: 22453202</p><li><p>19. Goodwin S.C., Vedantham S., McLucas B., et. al.: Preliminary experience with uterine artery embolization for uterine fibroids. J Vasc Interv Radiol 1997; 8: pp. 517-526. PubMed PMID: 9232565</p><li><p>20. Greenwood L.H., Glickman M.G., Schwartz P.E., et. al.: Obstetric and nonmalignant gynecologic bleeding: treatment with angiographic embolization. Radiology 1987; 164: pp. 155-159. PubMed PMID: 3495816</p><li><p>21. Keshavarzi A., Vaezy S., Noble M.L., et. al.: Treatment of uterine fibroid tumors in an in situ rat model using high-intensity focused ultrasound. Fertil Steril 2003; 80: pp. 761-767. PubMed PMID: 14505751</p><li><p>22. Kaufman C., Pollak J., Mojibian H.: What is too big? Uterine artery embolization of a large fibroid causing abdominal compartment syndrome. Semin Intervent Radiol 2014; 31: pp. 207-211. PubMed PMID: 25049449; PubMed Central PMCID: PMCPMC4078127</p><li><p>23. Spies J.B., Roth A.R., Jha R.C., et. al.: Leiomyomata treated with uterine artery embolization: factors associated with successful symptom and imaging outcome. Radiology 2002; 222: pp. 45-52. PubMed PMID: 11756703</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-22/'>Volume 22</a>, <a href='/categories/issue-9/'>Issue 9</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Three-Dimensional%20Quantitative%20Assessment%20of%20Lesion%20Response%20to%20MR-guided%20High-Intensity%20Focused%20Ultrasound%20Treatment%20of%20Uterine%20Fibroids%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fthree-dimensional-quantitative-assessment-of-lesion-response-to-mr-guided-high-intensity-focused-ult%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Three-Dimensional%20Quantitative%20Assessment%20of%20Lesion%20Response%20to%20MR-guided%20High-Intensity%20Focused%20Ultrasound%20Treatment%20of%20Uterine%20Fibroids%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fthree-dimensional-quantitative-assessment-of-lesion-response-to-mr-guided-high-intensity-focused-ult%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fthree-dimensional-quantitative-assessment-of-lesion-response-to-mr-guided-high-intensity-focused-ult%2F&text=Three-Dimensional%20Quantitative%20Assessment%20of%20Lesion%20Response%20to%20MR-guided%20High-Intensity%20Focused%20Ultrasound%20Treatment%20of%20Uterine%20Fibroids%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/3-tesla23-na-magnetic-resonance-imaging-during-aerobic-and-anaerobic-exercise/"><div class="card-body"> <em class="small" data-ts="1441040400" data-df="ll" > Aug 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>3 Tesla23 Na Magnetic Resonance Imaging During Aerobic and Anaerobic Exercise</h3><div class="text-muted small"><p> Rationale and Objectives The aim of the work described here was to determine the feasibility of monitoring Na + concentration and distribution in muscle/skin during aerobic/anaerobic exercise wit...</p></div></div></a></div><div class="card"> <a href="/posts/abbreviated-screening-protocol-for-breast-mri/"><div class="card-body"> <em class="small" data-ts="1441040400" data-df="ll" > Aug 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Abbreviated Screening Protocol for Breast MRI</h3><div class="text-muted small"><p> Rationale and Objectives To compare the performance of two shortened breast magnetic resonance imaging (MRI) protocols to a standard MRI protocol for breast cancer screening. Materials and Method...</p></div></div></a></div><div class="card"> <a href="/posts/adoption-of-the-16-month-american-board-of-radiology-pathway-to-dual-board-certifications-in-nuclear/"><div class="card-body"> <em class="small" data-ts="1441040400" data-df="ll" > Aug 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Adoption of the 16-Month American Board of Radiology Pathway to Dual Board Certifications in Nuclear Radiology and/or Nuclear Medicine for Diagnostic Radiology Residents</h3><div class="text-muted small"><p> We thank Dr Segall for his thoughtful comments and appreciate the opportunity to respond. Because our survey was conducted during the 2013–2014 academic year, the American Board of Radiology (ABR),...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/the-passive-voice/" class="btn btn-outline-primary" prompt="Older"><p>The Passive Voice</p></a> <a href="/posts/validation-of-a-semiautomated-liver-segmentation-method-using-ct-for-accurate-volumetry/" class="btn btn-outline-primary" prompt="Newer"><p>Validation of a Semiautomated Liver Segmentation Method Using CT for Accurate Volumetry</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
